ERBB2 and breast carcinoma: Breast cancer is divided into the following clinically relevant molecular subtypes: luminal A and B (ER/PR+ or both, HER2-); non-luminal (ER-, PR-, HER2+); basal-like or triple-negative (ER-, PR-, HER2-) [12].